Ryan David Lake - 03 Sep 2025 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Sep 2025, 16:42:03 UTC
Prior SEC filing
10 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Aaron S. Perlitsh, Attorney-In-Fact for Ryan Lake

Key filing fact

Ryan David Lake filed Form 4 for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) on 04 Sep 2025.

Key facts

  • This page summarizes Ryan David Lake's Form 4 filing for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Sep 2025, 16:42.

Change

  • Previous filing in this sequence was filed on 10 Jul 2025.
  • Current net transaction value: -$176,806.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001450325 Primary reporting owner

Lake Ryan David

Relationship
Chief Financial Officer
Address
C/O LIFECORE BIOMEDICAL, INC., 3515 LYMAN BLVD., CHASKA
Signature
/s/ Aaron S. Perlitsh, Attorney-In-Fact for Ryan Lake
Signature date
04 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LFCR transaction

Common Stock

Tax liability

Transaction value
$176,806
Shares
-22,932
Change %
-6.4%
Price
$7.71
Shares after
336,691
Date
03 Sep 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of an RSU vesting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .